Inventor

Paul D. Bishop

Inventor

Fall City, WA, US

Overview

53→

Patents

1993–2019

Patent span

Human necessities

Primary field (CPC A)

Patents· 53 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes33%

C07KPeptides19%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%

C12NMicroorganisms or enzymes9%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%

A61LMethods or apparatus for sterilising materials or objects in general4%

Y10TTechnical subjects covered by former us classification3%

C12YEnzymes2%

Y02ATechnologies for adaptation to climate change2%

C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%

PatentTitleYear

10,232,046Hemostatic microspheres2019 10,124,068Hemostatic microspheres2018 9,629,798'Hemostatic microspheres'2017 9,597,062'Medical devices for delivering fluids during surgery and methods for their use'2017 8,759,066'Thrombin activator compositions and methods of making and using the same'2014 7,977,309'Methods of using motilin homologs'2011 7,691,610'Human zven polynucleotides'2010 7,691,585'Human Zven polypeptides'2010 7,662,641'Method of using Zven antibodies'2010 7,429,566'Method for treating Hemophilia B'2008 7,354,739'TML polynucleotides'2008 7,335,642'Method for treating a viral infection related or a chemical toxin related hepatic injury with deltorphin D'2008 7,208,578'Adipocyte complement related protein homolog zacrp2'2007 7,179,787'Methods of using human Zven proteins'2007 7,153,830'Method for inhibiting the formation of seromas using factor XIII'2006 7,135,317'Polynucleotides encoding disintegrin homologs, and related products'2006 7,122,349'Human zven proteins'2006 7,115,559'Method for treating coumarin-induced hemorrhage'2006 7,060,792'Protection against ischemia and reperfusion injury'2006 7,008,926'Blood coagulation factor XIII for treating platelet disorders'2006 6,979,445'Method for treating von willebrand\'s disease'2005 6,939,690'Polynucleotides encoding motilin homologs'2005 6,921,649'Polynucleotide encoding adipocyte complement related protein homolog zacrp2'2005 6,900,178'Protection against ischemia and reperfusion injury'2005 6,897,286'Zsig33-like peptides'2005 6,890,903'Method for inhibiting the formation of seromas using factor XIII'2005 6,875,742'Method for treating cytokine mediated hepatic injury'2005 6,838,438'Motilin Homologs'2005 6,828,425'Antibodies that bind human Zven1'2004 6,780,411'Tissue sealant compositions'2004 6,762,044'Mammalian adhesion protease peptides'2004 6,756,479'Human Zven1 proteins'2004 6,645,938'Protection against ischemia and reperfusion injury'2003 6,627,729'TML peptides'2003 6,620,909'Adipocyte complement related protein homolog zacrp2'2003 6,544,946'Inhibitors for use in hemostasis and immune function'2003 6,521,233'Adipocyte complement related protein homolog zacrp3'2003 6,485,938'Nucleic acid molecules that encodes human Zven1'2002 6,448,221'Methods of promoting blood flow within the vasculature of a mammal'2002 6,420,521'Short gastrointestinal peptides'2002 6,420,154'Mammalian adhesion protease peptides'2002 6,380,164'Method for treating cytokine mediated hepatic injury'2002 6,316,411'Protection against ischemia and reperfusion injury'2001 6,294,519'Method for treating ischemia'2001 6,265,199'Disintegrin homologs'2001 5,965,389'Production of GAD65 in methylotrophic yeast'1999 5,834,232'Cross-linked gelatin gels and methods of making them'1998 5,710,174'Factor XIIIA inhibitor'1998 5,693,098'Fibrin D-domain multimer prostheses and methods for their production'1997 5,612,456'Factor XIII compositions'1997 5,609,631'Fibrin D-domain multimer coated prostheses and methods for their production'1997 5,324,647'Fibrin coated polymer surfaces'1994 5,204,447'Purification of factor XIII'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2014Patents assigned to ZYMOGENETICS INC (47)· patent assignee history

1993–2019Based in Fall City, WA, US· patent location history

2001–2008Patents assigned to UNIV KENTUCKY RES FOUND (7)· patent assignee history

2014–2017Patents assigned to BISHOP PAUL D (3)· patent assignee history

2017Patents assigned to MALLINCKRODT PHARMA IP TRADING D A C (2)· patent assignee history

2018–2019Patents assigned to BAXTER INT (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ZYMOGENETICS INC	47	1993–2014
UNIV KENTUCKY RES FOUND	7	2001–2008
BISHOP PAUL Dself	3	2014–2017
BAXTER INT	2	2018–2019
MALLINCKRODT PHARMA IP TRADING D A C	2	2017

Locations

Location	Patents	Span
Fall City, Washington, US	53	1993–2019